Zenith p-Branch Device Demonstrates Technical Success and Safety in Feasibility Study
November 26, 2019—Findings from a feasibility study of the Zenith p-Branch device (Cook Medical) for treating patients with asymptomatic juxtarenal or pararenal abdominal aortic aneurysms were published by Mark A. Farber, MD, et al in Journal of Vascular Surgery (JVS).
Zenith p-Branch is an off-the-shelf fenestrated device based on Cook’s Zenith platform, with two pivot renal fenestrations, a superior mesenteric artery (SMA) fenestration, and a celiac scallop.
The prospective, nonrandomized, multicenter, feasibility study was composed of 30 patients (93% men; mean age, 73 years; mean aneurysm diameter, 64.7 ± 11.4 mm) enrolled from January 2013 to June 2015. Eligible patients had an aneurysm that did not extend above the distal margin of the SMA, as well as renal and visceral artery anatomy compatible with one of the two p-Branch configurations. The mean follow-up period was 28.7 ± 12.5 months.
The p-Branch’s overall technical success rate was 93%. Technical failure occurred in the first two patients, although both patients survived the procedure and withdrew from the study. An updated physician training and proctoring program was then implemented, and no additional failures occurred.
As reported in JVS, there was no 30-day mortality. Three deaths occurred during follow-up, but these were unrelated to the device or procedure, as determined by clinical events committee adjudication.
Additionally, the investigators found:
-
No treated aneurysm rupture, conversion, core laboratory–adjudicated migration, or stent fracture
-
A primary renal artery patency rate of 88.6% ± 4.4% at 1 and 2 years
-
Renal insufficiency in two patients (7%)
-
No requirement for dialysis and no developed mesenteric ischemia
-
A 32% secondary intervention rate, with nine patients undergoing 13 secondary interventions
The investigators concluded that these results, which incorporated physician learning curves, support the safety and feasibility of the Zenith p-Branch device. Follow-up examinations through 5 years will assess the long-term results.
advertisement
Featured Video
The evolution of Medtronic
EVAR devices
Sponsored by Medtronic UC201806396E
Related Articles
Top 5 Articles From October 2019
What’s New in Y-90?
Technical and procedural innovations in Y-90 radioembolization including existing and investigational next-generation technologies.
By Robert Abraham, MD, FRCPC, FSIR; Robert Lewandowski, MD, FSIR; Ripal T. Gandhi, MD, FSIR, FSVM; and David M. Liu, MD, FRCPC, FSIR
Transradial Access for Hepatic Oncologic Interventions
Considerations for choosing the right access equipment.
By Darren Klass, MBChB, MD, MRCS, FCRC, FRCPC; Anastasia Hadjivassiliou, MBBS, FRCR, FRCPC; and John Chung, MD, FRCPC
Top Tips in Interventional Oncology
Clinical and technical insights into treating hepatocellular carcinoma, cholangiocarcinoma, renal cell carcinoma, lung cancer, bone cancer, and in the palliative care setting.
By Siddharth A. Padia, MD; Theodore Bryan, MD; Rebecca Bennett, MD; Nadine Abi-Jaoudeh, MD, FSIR, CCRP; Raul N. Uppot, MD; Robert Suh, MD; Paul I. Mallinson, MBChB, FRCR, FRCPC; Peter L. Munk, MDCM, FRCPC, FSIR, FFRRCSI (Hon); Miyuki Sone, MD; and Yasuaki Arai, MD, FSIR, FCIRSE
Contemporary Management of Pancreatic Cancer
An update on state-of-the-art minimally invasive therapies, including recent advances in surgery, radiation therapy, ablative options, and endovascular therapies.
By Ripal T. Gandhi, MD, FSIR, FSVM; Horacio Asbun, MD; Michael Chuong, MD; Filipe Kunzler, MD; and Govindarajan Narayanan, MD
Is It Time to End the Therapeutic Nihilism Toward Treating VTE in Cancer Patients?
Cases highlighting the potential for early benefit and improved quality of life and function associated with the use of FlowTriever and ClotTriever Systems in patients with cancer and VTE.
With Sirish A. Kishore, MD; and William C. Dillon, MD, FACC
Top 5 from CIToday's Current Issue
Meeting the Challenge…
By Azeem Latib, MD
Massive Thromboembolism, PFO, and Acute Limb Ischemia
By Moderator: Mohamad Alkhouli, MD
Panelists: Yashu Dhamija, MD; Abdul Moiz Hafiz, MD; Ankur Kalra, MD, FACP, FACC, FSCAI; and Anmar Kanaa’N, MD
Radial Access for the Evaluation of Bypass Grafts
By Moderator: Mirvat Alasnag, MD, FACP, FSCAI, FRCP
Panelists: James Nolan, MBChB, FRCP, MD; Sunil Rao, MD; and Binita Shah, MD, MS, FACC, FSCAI
Compensation and Production Trends for Interventionalists
A look at MedAxiom’s annual report reflecting the continued evolution of the field in terms of physician demand and compensation agreements.
